SCHEMBL8917491

SCHEMBL8917491

NCCCCCCOc1cc(Cl)ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
LMNA P02545 2/20 0.54
TSHR P16473 1/20 0.48
KDM4E B2RXH2 2/20 0.47
CYP2C19 P33261 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2D6 P10635 1/20 0.46
NOS2 P35228 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
DRD2 P14416 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11249902 0.87 ALDH1A1 (0.54) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL8918360 0.86 MAPT (0.53) ALDH1A1TSHRKDM4ECYP2C19CYP1A2
SCHEMBL8955786 0.84 ALDH1A1 (0.69) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL1311060 0.82 ALDH1A1 (0.54) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL28556250 0.82 ALDH1A1 (0.54) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL12978667 0.82 ALDH1A1 (0.54) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL196619 0.82 ALDH1A1 (0.54) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL8778628 0.82 ALDH1A1 (0.54) ALDH1A1LMNATSHRKDM4ECYP2C19
SCHEMBL8916142 0.79 DHFR (0.45) LMNATSHRHTR6SMN1; SMN2L3MBTL1
SCHEMBL98230 0.78 ALDH1A1 (0.50) ALDH1A1LMNATSHRKDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5696140-A FOR TREATMENT OF ASTHMA, ALLERGIES, NERVOUS SYSTEM DISORDERS OR CANCER LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1997-12-09 US disclosed